• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔镜辅助下肺段切除术治疗早期非小细胞肺癌的中长期疗效分析

Analysis of middle- and long-term efficacy of thoracoscope-assisted segmental resection of the lung on non-small cell lung cancer in the early stage.

作者信息

Ding Ning, Zhou Ning, Li Qinglin, Ren Guangming, Zhou Min

机构信息

Department of Respiratory Medicine, The Affiliated Xuzhou City Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China.

出版信息

Oncol Lett. 2018 Mar;15(3):3662-3668. doi: 10.3892/ol.2018.7789. Epub 2018 Jan 12.

DOI:10.3892/ol.2018.7789
PMID:29456731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5795914/
Abstract

We investigated the short- and long-term efficacy of thoracoscope-assisted segmental resection of lung of non-small cell lung cancer (NSCLC). We selected a total of 94 patients with lung cancer in the early stage who were admitted to The First People's Hospital of Xuzhou for treatment between March 2011 and February 2012. Patients were divided randomly into either the control group (n=47) or the observation group (n=47). In the observation group, patients received thoracoscope-assisted segmental resection of lung, while in the control group, the conventional thoracic surgery was performed for treatment. After surgeries, we observed the incidence rate of complications among the two groups, and enzyme-linked immunosorbent assay (ELISA) was adopted to detect levels of inflammatory factors. We also compared the cardiac and pulmonary functions, the levels of immunoglobulins and subgroups of T lymphocytes in the peripheral blood of the patients. In addition, all patients attended a 5-year follow-up to determine the recurrence and survival rate. Compared to the control group, patients in the observation group had significantly less intra-operative bleeding volume, a shorter duration of surgery, and suffered slighter pain after surgery (P<0.05). After surgery, the incidence rate of complications in the observation group was significantly lower than that in the control group (P<0.05). After surgeries, patients in both groups experienced a remarkable improvement in cardiac and pulmonary functions, and the improvement in the observation group was superior to that of the control group (P<0.05). During the 5-year follow-up, the survival rate of the observation group is significantly higher than that in thecontrol group, and patients in the observation group experienced a lower recurrence rate than those in the control group (P<0.05). Thus, thoracoscope-assisted segmental resection of lung is of great significance in clinical practice.

摘要

我们研究了胸腔镜辅助下非小细胞肺癌(NSCLC)肺段切除术的短期和长期疗效。我们选取了2011年3月至2012年2月期间在徐州市第一人民医院接受治疗的94例早期肺癌患者。将患者随机分为对照组(n = 47)和观察组(n = 47)。观察组患者接受胸腔镜辅助下肺段切除术,而对照组则采用传统开胸手术治疗。手术后,我们观察两组并发症的发生率,并采用酶联免疫吸附测定(ELISA)检测炎症因子水平。我们还比较了患者的心肺功能、外周血免疫球蛋白水平和T淋巴细胞亚群。此外,所有患者均进行了5年随访,以确定复发率和生存率。与对照组相比,观察组患者术中出血量明显减少,手术时间缩短,术后疼痛较轻(P < 0.05)。术后,观察组并发症发生率明显低于对照组(P < 0.05)。手术后,两组患者的心肺功能均有显著改善,且观察组的改善程度优于对照组(P < 0.05)。在5年随访期间,观察组的生存率明显高于对照组,且观察组患者的复发率低于对照组(P < 0.05)。因此,胸腔镜辅助下肺段切除术在临床实践中具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e3/5795914/a634b9fbee4d/ol-15-03-3662-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e3/5795914/a634b9fbee4d/ol-15-03-3662-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e3/5795914/a634b9fbee4d/ol-15-03-3662-g00.jpg

相似文献

1
Analysis of middle- and long-term efficacy of thoracoscope-assisted segmental resection of the lung on non-small cell lung cancer in the early stage.胸腔镜辅助下肺段切除术治疗早期非小细胞肺癌的中长期疗效分析
Oncol Lett. 2018 Mar;15(3):3662-3668. doi: 10.3892/ol.2018.7789. Epub 2018 Jan 12.
2
Evaluation of efficacy and safety of minimally invasive segmentectomy in the treatment of lung cancer.微创肺段切除术治疗肺癌的疗效与安全性评估
Oncol Lett. 2018 Jun;15(6):9516-9522. doi: 10.3892/ol.2018.8483. Epub 2018 Apr 13.
3
Safety and effectiveness of localized lung resection combined with neoadjuvant chemotherapy in the treatment of stage I-II non-small cell lung cancer.局部肺切除联合新辅助化疗治疗Ⅰ-Ⅱ期非小细胞肺癌的安全性和有效性
Oncol Lett. 2017 Apr;13(4):2344-2348. doi: 10.3892/ol.2017.5675. Epub 2017 Feb 3.
4
[Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].[舒更葡糖钠用于胸腔镜下肺癌根治术患者拮抗神经肌肉阻滞的分析]
Zhonghua Yi Xue Za Zhi. 2020 Jan 21;100(3):213-219. doi: 10.3760/cma.j.issn.0376-2491.2020.03.011.
5
Outcome and Safety of Radical Resection in Non-Small Cell Lung Cancer Patients via Glasses-Free 3-Dimensional Video-Assisted Thoracoscope Versus 2-Dimensional Video-Assisted Thoracoscope.非小细胞肺癌患者通过免眼镜三维电视辅助胸腔镜与二维电视辅助胸腔镜进行根治性切除的疗效及安全性
Surg Innov. 2018 Apr;25(2):121-127. doi: 10.1177/1553350617754102. Epub 2018 Jan 22.
6
Clinical controlled comparison between lobectomy and segmental resection for patients over 70 years of age with clinical stage I non-small cell lung cancer.对于 70 岁以上临床 I 期非小细胞肺癌患者,行肺叶切除术与肺段切除术的临床对照研究。
Eur J Surg Oncol. 2012 Dec;38(12):1149-55. doi: 10.1016/j.ejso.2012.08.001. Epub 2012 Aug 15.
7
Long-term Outcomes of Thoracoscopic Anatomic Resections and Systematic Lymphadenectomy for Elderly High-risk Patients with Stage IB Non-small-cell Lung Cancer.老年高危ⅠB期非小细胞肺癌患者胸腔镜解剖性切除及系统性淋巴结清扫的长期结局
Heart Lung Circ. 2016 Apr;25(4):392-7. doi: 10.1016/j.hlc.2015.08.022. Epub 2015 Oct 8.
8
Different limited resection of pulmonary lobe methods under the thoracoscopy in the treatment of early nonsmall cell lung cancer occurred in the old age.
Indian J Cancer. 2015 Feb;51 Suppl 2:e29-32. doi: 10.4103/0019-509X.151995.
9
[Comparison Study of Post-operative Pain and Short-term Quality of Life between Uniportal and Three Portal Video-assisted Thoracic Surgery for Radical Lung Cancer Resection].单孔与三孔电视辅助胸腔镜手术根治性肺癌切除术后疼痛及短期生活质量的比较研究
Zhongguo Fei Ai Za Zhi. 2016 Mar;19(3):122-8. doi: 10.3779/j.issn.1009-3419.2016.03.02.
10
A Study of Complete Video-Assisted Thoracoscopic Surgery Lobectomy in Treatment of Elderly Patients with Non-Small Cell Lung Cancer: Curative Effect and Impact on Clinical Prognosis.全胸腔镜肺叶切除术治疗老年非小细胞肺癌的疗效及对临床预后影响的研究
Cell Biochem Biophys. 2015 Nov;73(2):399-404. doi: 10.1007/s12013-015-0649-x.

引用本文的文献

1
The clinical effect of thoracoscopic segmentectomy in the treatment of lung malignancies less than 2CM in diameter.胸腔镜肺段切除术治疗直径小于 2CM 肺部恶性肿瘤的临床效果。
J Cardiothorac Surg. 2024 Oct 29;19(1):616. doi: 10.1186/s13019-024-03030-0.
2
Clinical therapeutic effects and prognosis of video-assisted thoracoscopic surgery-guided pulmonary lobectomy combined with mediastinal lymph node dissection in lung carcinoma.电视胸腔镜手术引导下肺癌肺叶切除术联合纵隔淋巴结清扫术的临床治疗效果及预后
Am J Cancer Res. 2023 Nov 15;13(11):5138-5150. eCollection 2023.

本文引用的文献

1
Leucine-rich repeats and immunoglobulin-like domains protein 1 and fascin actin-bundling protein 1 expression in nonsmall cell lung cancer.富含亮氨酸重复序列和免疫球蛋白样结构域蛋白1及丝束蛋白肌动蛋白束集蛋白1在非小细胞肺癌中的表达
J Cancer Res Ther. 2016 Dec;12(Supplement):C248-C251. doi: 10.4103/0973-1482.200749.
2
The prognostic influence of tumor infiltrating Foxp3(+)CD4(+), CD4(+) and CD8(+) T cells in resected non-small cell lung cancer.肿瘤浸润性Foxp3(+)CD4(+)、CD4(+)和CD8(+) T细胞对可切除非小细胞肺癌的预后影响
J Inflamm (Lond). 2015 Nov 23;12:63. doi: 10.1186/s12950-015-0108-x. eCollection 2015.
3
NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance.
非小细胞肺癌:驱动基因突变的最新进展、其在发病机制中的作用及临床意义
R I Med J (2013). 2015 Oct 1;98(10):25-8.
4
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.纳武利尤单抗对比多西他赛治疗晚期非鳞状非小细胞肺癌
N Engl J Med. 2015 Oct 22;373(17):1627-39. doi: 10.1056/NEJMoa1507643. Epub 2015 Sep 27.
5
Systemic and alveolar inflammatory response in the dependent and nondependent lung in patients undergoing lung resection surgery.肺切除手术患者中,非下垂肺和下垂肺的全身及肺泡炎症反应。
Eur J Anaesthesiol. 2016 Jan;33(1):63-4. doi: 10.1097/EJA.0000000000000333.
6
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.IV期非小细胞肺癌的全身治疗:美国临床肿瘤学会临床实践指南更新
J Clin Oncol. 2015 Oct 20;33(30):3488-515. doi: 10.1200/JCO.2015.62.1342. Epub 2015 Aug 31.
7
Video-assisted thoracoscopic surgery lobectomy for lung cancer is associated with a lower 30-day morbidity compared with lobectomy by thoracotomy.与开胸肺叶切除术相比,电视辅助胸腔镜手术肺叶切除术治疗肺癌的30天发病率更低。
Eur J Cardiothorac Surg. 2016 Mar;49(3):870-5. doi: 10.1093/ejcts/ezv205. Epub 2015 Jun 18.
8
Refining the treatment of NSCLC according to histological and molecular subtypes.根据组织学和分子亚型细化 NSCLC 的治疗。
Nat Rev Clin Oncol. 2015 Sep;12(9):511-26. doi: 10.1038/nrclinonc.2015.90. Epub 2015 May 12.
9
Pembrolizumab for the treatment of non-small-cell lung cancer.帕博利珠单抗治疗非小细胞肺癌。
N Engl J Med. 2015 May 21;372(21):2018-28. doi: 10.1056/NEJMoa1501824. Epub 2015 Apr 19.
10
VATS versus open surgery for lung cancer resection: moving toward a minimally invasive approach.胸腔镜手术与开胸手术治疗肺癌切除:向微创方法发展。
J Natl Compr Canc Netw. 2015 Feb;13(2):162-4. doi: 10.6004/jnccn.2015.0023.